N-(4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)formamide
- CAS
- 1144516-20-0
- Formula
- C25H20ClN5O3
- MW
- 473.9 g/mol
VQ-028936
Impurity reference standards
Neratinib impurities & reference standards
Characterised Neratinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
15reference materials
1nitrosamine impurities
1isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Neratinib WS
698387-09-6 · C30H29ClN6O3
FAQs — Neratinib impurities
Which Neratinib impurities do you supply?
We list 15 Neratinib-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Neratinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Neratinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Neratinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.